Suppressed immune systems post-covid, esp in those with diabetes and who were treated with steroids, are left open to a common but dangerous fungal infection that normally poses no threat to healthy people.
IIRC, that dose is higher than for a horse … a lot lower than for a dog, though. 
Isn’t this where that Ivermectin study was done? Just kidding.
And to prove that he’s serious, the pope is offering 50-year, rent-free leases to lots of desirably located Diocese owned properties to those drug companies. Otherwise, he’s no better than governments - taking property that doesn’t belong to them.
It’s so wonderful to see you quote, and so strongly back the Pope. I would have thought that you had little regard for leaders of organized religion. Where is your “abortion is MURDER!” poster?
ETA: If you really are a practicing Catholic and against abortion, my apologies and peace be with you.
Fauci getting a hard time on the NIH funding grants to Wuhan Virology Lab for dangerous virus research.
If I recall correctly, gain of function work had to have some additional documentation or supervision when it was allowed to be resumed after the Obama era ban. But under Fauci, that either didn’t happen or was granted to exception to allow the Chinese lab work to continue. Hard to imagine this met the Obama standard for gain of function supervision of “there is no safer way to do this work than paying a lab with shoddy safety practices half way across the world do it in China instead of here in the NIH”.
LOL. Quick, someone make a “I’m shedding ‘certain’ proteins, better put on your mask!” t-shirt.
On the Indian variants
https://www.wsj.com/articles/india-covid-19-variant-11620722888
The variant, identified in October, is a mutant form of the virus that causes Covid-19. It has 13 mutations, including two notable ones in the spike protein that the virus uses to attach to and infect cells.
One of the mutations, dubbed E484Q, is similar to one that is common to the variants identified in South Africa and Brazil. In those variants, the mutation seems to make the virus better at evading the body’s immune responses. The other, known as L452R, is also found in the dominant strain in California, and may boost viral transmission.
Antibody responses seem only slightly reduced compared to the Wuhan classic version, so the existing vaccines should still be quite effective.
Indian relief gets a ton of crypto donations, value unclear.
Moderna focused article touches on the recent IP threats posed by our government and the relevant laws.
In late March the Biden administration, at the urging of Democratic lawmakers, held a sub-cabinet level meeting of government administrators to discuss the U.S. government’s ability to suspend IP rights of the vaccine makers. Specifically discussed was the 1980 Bayh-Dole Act that allows for the federal government to “march in” and issue a compulsory license for a federally funded invention, if the invention is not available to the public under reasonable terms. Practically, this means the federal government could break patents for federally funded vaccines or drugs to authorize generic competition if regulators determine the price is exorbitantly high. The Trump administration had proposed a rule to modify the Bayh-Dole Act by saying the government cannot use its march-in authority solely based on price. Comments on this proposed rule closed April 5.
The government’s “march-in” ability is not clear when the matter in question transcends price. As I pointed out in this article, Joe Allen, executive director of the Bayh-Dole Coalition, whose members include drug makers, says that lawmakers’ misapprehend the act and their efforts could backfire. Allen argues that Congress never intended the government to set prices on products and the law makes no reference to what is considered a reasonable price as dictated by the government. He says advocates and politicians have been purposefully misinterpreting the law for years.
“It will stop collaboration,” Allen said, of enforcing march-in rights. “The danger is the next time you have a pandemic, are companies going to jump-in to partner with you (the government)?”
Current COVID-19 drug and vaccine U.S. contracts vary on “march-in” rights. Moderna’s contract contains the standard march-in clause, and Novavax’s vaccine contract generally tracks with the Bayh-Dole Act, according to Knowledge Ecology International, a nonprofit group whose precursor organization was founded by consumer advocate Ralph Nader. Johnson & Johnson’s contract limits march-in rights to the time during the current pandemic. The Pfizer (PFE)/BioNTech (BNTX) vaccine was developed entirely with private funds and prohibits the government from marching in, so suspending their IP might not be legally enforceable. However, that remains a question.
In addition to all those limits, the “price” reasoning is ridiculous considering how much money our government is throwing around on things that have nothing to do with the pandemic.
interesting pair of items in the news. but where there’s smoke there’s fire. The left would love to have another way to control us
Orange County to test digital COVID-19 vaccine passport program
Following public backlash, officials clarify that Orange County will not require a ‘vaccine passport’
But but but it isn’t gonna be required! (…as long as you have no interest in leaving your house.)
See, I wasn’t entirely wrong when I mentioned that they took billions of government money. I didn’t mention Pfizer in my post at all, as they didn’t take the money for R&D or distribution but only for a conditional pre-sale of the product, and it’s not clear that their IP could be waived.
As xerty’s above article points out, nobody changed their mind – the “march-in” rights were already in the contract!
I think that’s the definition of red herring. The “price” of the drug has nothing to do with what other things the government might be spending money on.
Except Orange County (CA) leans Republican.
How is it a red herring to look at the totality of the circumstances when deciding whether a government policy is a good idea?
…if the product is not being made available to the public under reasonable terms. With all the manufacturers producing as many doses as they can and selling them all directly to the government for distribution to the public, that’s a real tough sell. A really really tough sell.
And I’m pretty sure it doesnt apply, or at least isnt intended to apply, to our government ganking the IP for the benefit of foreign countries. Had, for example, Moderna started exporting all their vaccine to Europe and telling the US that we’ll just have to wait, that would’ve triggered the “march-in” rights.
“Republicans” may be the ones calling it out, but the concept of the government controlling us - “the swamp” - transcends political affiliation.
OK, but don’t pretend you knew all that when you ridiculed my comment by saying that they can’t change the contract after the fact 
.